Analysts consider Ebos’ result a solid one

Analysts consider Ebos’ result a solid one
Jarden analysts have upgraded their rating for Ebos. (Image: Getty)
Ella Somers
Analysts feel upbeat but cautious about the future after healthcare wholesaler Ebos posted a better-than-expected full-year result on Wednesday.Jarden analysts Adrian Allbon and Nick Yeo upgraded their rating from underweight to neutral for the company.“Underlying cashflows were stronger than expected, with a beat on final dividend and lower net debt versus our expectations,” they wrote.Jarden's other highlights for the company included the LifeHealthcare acquisition performing “in line” with management expectations...

More Markets

Takeover bid is opportunistic and undervalued: THL
Markets

Takeover bid is opportunistic and undervalued: THL

Tourism Holdings' board remains open to engagement with the Consortium.

One man, five boards: The NZ director spiderweb
Markets

One man, five boards: The NZ director spiderweb

James Miller is at the top of the directorship pyramid.

Increased US tariffs drive NZ stocks lower
Markets Market Close

Increased US tariffs drive NZ stocks lower

F&P Healthcare and Ebos shares both dropped over 2% on the tariff news.

Jamie Gray 01 Aug 2025
Journee to succeed Withers as Warehouse chair
Retail

Journee to succeed Withers as Warehouse chair

Journee ensures "strong continuity of leadership", Joan Withers said.

Gregor Thompson 01 Aug 2025